https://investors.agexinc.com/generated by Q4Sat, 11 Apr 2026 23:54:27 -0400Copyright Q4 Inc. All rights reserved.0107b726-d791-420f-aef2-e6fd75dadd24https://investors.agexinc.com/news/news-details/2024/Serina-Therapeutics-Announces-Completion-of-Merger-with-AgeX-Therapeutics/default.aspxTue, 26 Mar 2024 17:04:00 -0400ff4bc708-9583-4533-957e-4509774ffccbhttps://investors.agexinc.com/news/news-details/2024/AgeX-Therapeutics-Reports-Fourth-Quarter-and-Annual-2023-Financial-Results/default.aspxFri, 22 Mar 2024 17:27:00 -0400fd4be5df-1038-4304-889a-068ad3155c39https://investors.agexinc.com/news/news-details/2023/AgeX-Therapeutics-Reports-Third-Quarter-2023-Financial-Results/default.aspxTue, 14 Nov 2023 16:05:00 -050043f0c922-9572-4a6d-a10c-1cc5e55f2fe1https://investors.agexinc.com/news/news-details/2023/Serina-Therapeutics-and-AgeX-Therapeutics-Enter-into-Merger-Agreement/default.aspxWed, 30 Aug 2023 07:00:00 -0400ee75467f-94e4-409f-beb3-d411be66878ehttps://investors.agexinc.com/news/news-details/2023/AgeX-Therapeutics-Reports-Second-Quarter-2023-Financial-Results/default.aspxMon, 14 Aug 2023 16:05:00 -04002dc8b6f2-ce36-464a-8732-532d6ed6b5fehttps://investors.agexinc.com/news/news-details/2023/AgeX-Therapeutics-Closes-36000000-Debt-Exchange-for-Preferred-Stock/default.aspxMon, 24 Jul 2023 18:28:00 -04000d3a933f-0695-4f33-949d-6cab34ad7bd5https://investors.agexinc.com/news/news-details/2023/AgeX-Therapeutics-Announces-36000000-Debt-Exchange-for-Preferred-Stock/default.aspxFri, 21 Jul 2023 17:32:00 -04008b70cad5-9d2b-419d-8c59-2c20a3e38440https://investors.agexinc.com/news/news-details/2023/AgeX-Therapeutics-Announces-Appeal-of-NYSE-American-Determination/default.aspxTue, 23 May 2023 16:05:00 -0400f13c635f-25e6-40b7-a93d-5d80eab1af7bhttps://investors.agexinc.com/news/news-details/2023/AgeX-Therapeutics-Reports-First-Quarter-2023-Financial-Results/default.aspxFri, 12 May 2023 16:05:00 -0400253e0855-ddaa-496f-954e-3b84f35d9fe7https://investors.agexinc.com/news/news-details/2023/AgeX-Therapeutics-Receives-Stock-Exchange-Deficiency-Letter/default.aspxWed, 26 Apr 2023 16:05:00 -0400